KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Cash from Investing Activities (2018 - 2025)

Vir Biotechnology's Cash from Investing Activities history spans 8 years, with the latest figure at $86.7 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 38.43% to $86.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $310.4 million, a 37.85% decrease, with the full-year FY2025 number at $310.4 million, down 37.85% from a year prior.
  • Cash from Investing Activities hit $86.7 million in Q4 2025 for Vir Biotechnology, up from $40.4 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for VIR hit a ceiling of $230.3 million in Q2 2023 and a floor of -$662.6 million in Q3 2022.
  • Historically, Cash from Investing Activities has averaged -$18.0 million across 5 years, with a median of $65.2 million in 2021.
  • Biggest five-year swings in Cash from Investing Activities: soared 612.09% in 2021 and later tumbled 997.12% in 2022.
  • Tracing VIR's Cash from Investing Activities over 5 years: stood at -$377.6 million in 2021, then surged by 59.44% to -$153.1 million in 2022, then skyrocketed by 31.56% to -$104.8 million in 2023, then surged by 234.28% to $140.7 million in 2024, then tumbled by 38.43% to $86.7 million in 2025.
  • Business Quant data shows Cash from Investing Activities for VIR at $86.7 million in Q4 2025, $40.4 million in Q3 2025, and $56.5 million in Q2 2025.